Jackson Acquisition Company II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2024 and is based in Alpharetta, Georgia.…
Jackson Acquisition Company II (NYSE: JACS) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Shell Companies industry, part of the Financial Services sector.
The shares were at 10.87 USD on 20 November 2026, up 4.2% over 52 weeks. Its 52-week range is 10.41 USD to 10.88 USD, and it trades at the top of that range.
At a market capitalisation of 321.64M USD, it trades at 38.8 times trailing earnings. The median trailing P/E of its 5 largest Shell Companies peers is 36.0, so JACS is valued in line with them.
Jackson Acquisition Company II reports return on equity of 3.8% and an operating margin of 0.0%.
It holds more cash than debt, a net cash position of 98.23K USD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.